









Markets
/
Stocks
/
nasdaq-bhc
/

Bausch Health Companies Inc

BHC

View Detailed Chart

5.710USD

-0.175-2.97%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

2.11BMarket Cap

LossP/E TTM



Bausch Health Companies Inc

5.710

-0.175-2.97%

Overview Company Financials

Financials

Intraday

30m

Today

-2.97%

5 Days

-15.66%

1 Month

-19.12%

6 Months

-21.57%

Year to Date

-29.16%

1 Year

+1.42%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

HOLD

Current Rating

7.083

Target Price

24.05%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Bausch Health Companies Inc

BHC

Biogen Inc

BIIB

Alnylam Pharmaceuticals Inc

ALNY

Vertex Pharmaceuticals Inc

VRTX

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(2)

Buy(0)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.255

Neutral

RSI(14)

35.363

Neutral

STOCH(KDJ)(9,3,3)

22.982

Sell

ATR(14)

0.286

High Vlolatility

CCI(14)

-203.785

Oversold

Williams %R

86.875

Oversold

TRIX(12,20)

0.223

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

6.340

Sell

MA10

6.473

Sell

MA20

6.496

Sell

MA50

5.894

Sell

MA100

5.734

Sell

MA200

6.775

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Ticker SymbolBHC

CompanyBausch Health Companies Inc

CEOMr. Thomas J. Appio

Websitehttps://www.bauschhealth.com/